GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. The Journal Of Pharmacology And Experimental Therapeutics, 371(2), 526-543. https://doi.org/10.1124/jpet.119.258699
. (2019).